Medications

FDA still skeptical of ALS drug ahead of high-stakes meeting

Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, even as they prepare to give its drugmaker a rare second opportunity ...

Health

Napping more frequent in women with chronic migraine

Women with chronic migraine (CM) report significantly more days with naps than healthy controls, and nap duration is associated with headache severity, according to a study published online March 23 in Behavioral Sleep Medicine.

Medications

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

page 2 from 6